Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Certara, Inc.
  6. Summary
    CERT   US15687V1098

CERTARA, INC.

(CERT)
  Report
Delayed Quote. Delayed Nasdaq - 10/22 04:00:00 pm
38.13 USD   -1.14%
10/21INSIDER SELL : Certara
MT
10/19Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
GL
10/18INSIDER SELL : Certara
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
36.6(c) 37.96(c) 38.25(c) 38.57(c) 38.13(c) Last
352 922 410 949 455 339 233 616 223 097 Volume
-3.28% +3.72% +0.76% +0.84% -1.14% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 287 M - -
Net income 2021 -0,35 M - -
Net cash position 2021 42,0 M - -
P/E ratio 2021 3 813x
Yield 2021 -
Sales 2022 327 M - -
Net income 2022 11,5 M - -
Net cash position 2022 123 M - -
P/E ratio 2022 545x
Yield 2022 -
Capitalization 6 086 M 6 086 M -
EV / Sales 2021 21,1x
EV / Sales 2022 18,3x
Nbr of Employees 875
Free-Float 93,7%
More Financials
Company
Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software and technology to transform traditional drug discovery and development. Biosimulation is a technology used to conduct virtual trials using virtual patients to better understand how drugs behave in different individuals. The Company builds its... 
Sector
Software
Calendar
03/03Earnings Release
More about the company
Ratings of Certara, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about CERTARA, INC.
10/21INSIDER SELL : Certara
MT
10/19Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
GL
10/18INSIDER SELL : Certara
MT
10/12CERTARA : Appoints Patrick F. Smith to President of Integrated Drug Development
AQ
10/12Certara, Inc. Announces Executive Changes
CI
10/05CERTARA : Appoints Drayton T. Virkler as Chief Commercial Officer
AQ
10/05Certara Appoints Drayton T. Virkler as Chief Commercial Officer
CI
10/04CERTARA : Complementary technologies accelerate and help assure success in the drug develo..
PU
10/04CERTARA : Completes Acquisition of Pinnacle 21
AQ
10/04CERTARA, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
AQ
10/01Certara, Inc. completed the acquisition of Pinnacle 21, LLC for approximately $310 mill..
CI
09/30CERTARA : Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Su..
GL
09/30Certara Launches New Synchrogenix Writer Software to Accelerate the Regulatory Submissi..
CI
09/28INSIDER SELL : Certara
MT
09/22CERTARA : Announces New Clinical Science Group and Adds Senior Scientific Experts
AQ
More news
News in other languages on CERTARA, INC.
10/18VENTE D'INITIÉS : Certara
09/20Certara obtient une subvention de la FDA pour accélérer le développement de médicaments..
09/09Certara propose une offre d'actions à 31 dollars par action
09/03Certara prévoit un appel public à l'épargne de 20 millions d'actions ; l'action augment..
03/23IRW-PRESS : NeonMind Biosciences Inc.: NeonMind CEO gibt Update zum Fortschritt im Forschu..
More news
Analyst Recommendations on CERTARA, INC.
More recommendations
Chart CERTARA, INC.
Duration : Period :
Certara, Inc. Technical Analysis Chart | CERT | US15687V1098 | MarketScreener
Technical analysis trends CERTARA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 38,13 $
Average target price 37,75 $
Spread / Average Target -1,00%
EPS Revisions
Managers and Directors
William F. Feehery Chief Executive Officer & Director
Michael Andrew Schemick Chief Financial Officer
Sherilyn S. McCoy Chairman
James E. Cashman Independent Director
Eric Liu Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CERTARA, INC.13.08%6 086
MICROSOFT CORPORATION39.00%2 321 142
SEA LIMITED78.50%196 181
ATLASSIAN CORPORATION PLC80.96%106 965
ZOOM VIDEO COMMUNICATIONS, INC.-17.71%82 477
DASSAULT SYSTÈMES SE40.43%71 364